Chiesi USA
Chiesi USA, headquartered in Cary, North Carolina, specializes in pharmaceutical solutions for respiratory, neonatology, and special care, and is recognized as a B Corp for its commitment to sustainability and social responsibility.
Headquarters and Global Presence
Chiesi USA is headquartered in Cary, North Carolina. The company maintains a global presence with operations in over 100 countries including Austria, Belgium, Brazil, Bulgaria, China, Czech Republic, France, Germany, Greece, Hungary, Italy, Mexico, Pakistan, Poland, Romania, Russian Federation, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, Turkey, United Kingdom, and the United States. Part of the global Chiesi Group based in Parma, Italy, Chiesi USA exemplifies its parent company's commitment to healthcare innovation and quality.
Pharmaceutical Products
Chiesi USA specializes in pharmaceutical solutions for respiratory, neonatology, and special care. Key products include BETHKIS (Tobramycin Inhalation Solution), BRONCHITOL (mannitol) inhalation powder, CLEVIPREX (clevidipine) injectable emulsion, CUROSURF (poractant alfa) Intratracheal Suspension, KENGREAL (cangrelor) for injection, and RETAVASE (reteplase) for injection. These products address acute, rare, and chronic disorders, particularly in hospital and specialty care settings.
Research and Development
Chiesi USA is deeply engaged in research and development focusing on respiratory diseases, neonatology, and special care. The company's R&D efforts aim to advance medical treatments and improve patient outcomes in these specialized fields. Through continuous innovation, Chiesi USA seeks to address unmet medical needs and contribute to the overall advancement of pharmaceutical sciences.
Commitment to Sustainability and Social Responsibility
Chiesi USA operates as a Public Benefit Corporation and is a Certified B Corporation, reflecting its commitment to sustainability and social responsibility. The company's initiatives include substantial investments in environmentally friendly practices and community health programs. Recognized for its ethical business practices and contributions to social good, Chiesi USA balances profitability with a strong sense of corporate responsibility.
Patient Support and Community Programs
Chiesi USA provides various patient support programs, including financial assistance and copay programs, to ensure patients can access needed medications. Additionally, the company offers a grant program supporting medical education and community health initiatives. Through the 'Chiesi in the Community' program, Chiesi USA underscores its dedication to enhancing community well-being and supporting healthcare professionals.